A randomized phase II study evaluating different schedules of nab-paclitaxel in metastatic breast cancer
A randomized phase II study evaluating different schedules of nab-paclitaxel in metastatic breast cancer
Alessandra Gennari, MD, (Division of Medical Oncology E.O. Galliera)
Guy Jerusalem, MD, PhD (CHU Sart Tilman and University of Liège)